Büyükcavlak M, 2025-10-22: Case report in which a pregnant woman with congenital methemoglobinemia was managed with preoperative intravenous ascorbic acid and methylene blue held in reserve for delivery.
Spinal anesthesia was performed following preoperative administration of 1 g intravenous ascorbic acid, with methylene blue kept available as rescue therapy.
Büyükcavlak M, 2025-10-22: Case report in which a pregnant woman with congenital methemoglobinemia was managed with preoperative intravenous ascorbic acid and methylene blue held in reserve for delivery. C4. Study type: single case report (Int J Obstet Anesth 2026; article 104807), N=1, 38 weeks plus 4 days gestation, Konya City Hospital, Turkey. MetHb 16.9%, SpO2 70% on pulse oximetry; near-infrared spectroscopy used for cerebral oximetry. Dose of methylene blue (if given) not stated. PARTLY SUPPORTS: the clinicians chose ascorbic acid first in pregnancy and kept methylene blue as rescue, consistent with the label's pregnancy warning rather than with routine methylene blue use. Funder/conflicts not stated. Study type: case report.
